Click here to register—ARM members use REGMED20 to get a 20% discount!
Monday, February 22, 2016
9:00 AM
Opening Remarks
Sonya Dougal, PhD, New York Academy of Sciences
Jane Lebkowski, PhD, Asterias Biotherapeutics
9:15 AM
iPSC-based Cell Therapy: Issues and Solutions
Mahendra Rao, PhD, Wake Forest University School of Medicine
9:55 AM
Engineering Genetic Cures: Genome Editing of Stem Cells
Edward Lanphier, Sangamo BioSciences Inc
10:35 AM
Networking Coffee Break
10:55 AM
Stem Cell Transplantation for Neurodegenerative Disease: The Case for ALS
Jonathan Glass, MD, Emory ALS Center
11:35 AM
TBD
John F. DiPersio, MD, PhD, Washington University School of Medicine
12:15 PM
Networking Lunch and Poster Session
1:15 PM
TBD
Jane S Lebkowski, PhD, Asterias Biotherapeutics
1:55 PM
Mechanism of Action of PLX – Placental-Derived Cellular Therapy
Racheli Ofir, PhD, Pluristem LTD
2:35 PM
Development of Stem-Cell Derived, Macroencapsulated Islet Replacement for Type 1 Diabetes
Thomas Schulz, PhD, ViaCyte, Inc.
3:15 PM
Networking Coffee Break
3:35 PM
Neural Stem Cell Treatment for Stroke Disability
John Sinden, PhD, ReNeuron Limited
4:15 PM
TBD
Kathleen Tsokas, Esq, Janssen/Johnson & Johnson
4:55 PM
Closing Remarks and Poster Award Presentation
George Zavoico, PhD, JonesTrading Institutional Services
5:00 PM
Networking Reception
6:00 PM
Close
